KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Pension (2017 - 2025)

Novartis Ag's Pension history spans 9 years, with the latest figure at $1.6 billion for Q4 2025.

  • On a quarterly basis, Pension rose 4.07% to $1.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 billion, a 4.07% increase, with the full-year FY2025 number at $1.6 billion, up 4.07% from a year prior.
  • Pension hit $1.6 billion in Q4 2025 for Novartis Ag, up from $1.6 billion in the prior quarter.
  • Over the last five years, Pension for NVS hit a ceiling of $2.6 billion in Q4 2021 and a floor of $1.6 billion in Q4 2024.
  • Historically, Pension has averaged $1.9 billion across 5 years, with a median of $1.7 billion in 2022.
  • Biggest five-year swings in Pension: plummeted 34.73% in 2022 and later rose 5.34% in 2023.
  • Tracing NVS's Pension over 5 years: stood at $2.6 billion in 2021, then plummeted by 34.73% to $1.7 billion in 2022, then grew by 5.34% to $1.8 billion in 2023, then decreased by 13.44% to $1.6 billion in 2024, then rose by 4.07% to $1.6 billion in 2025.
  • Business Quant data shows Pension for NVS at $1.6 billion in Q4 2025, $1.6 billion in Q4 2024, and $1.8 billion in Q4 2023.